As of 2025-07-08, the Intrinsic Value of Yuyu Pharma Inc (000220.KS) is 9,111.93 KRW. This 000220.KS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 4,560.00 KRW, the upside of Yuyu Pharma Inc is 99.80%.
The range of the Intrinsic Value is 7,296.54 - 12,347.59 KRW
Based on its market price of 4,560.00 KRW and our intrinsic valuation, Yuyu Pharma Inc (000220.KS) is undervalued by 99.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 7,296.54 - 12,347.59 | 9,111.93 | 99.8% |
| DCF (Growth 10y) | 8,779.14 - 14,796.61 | 10,948.67 | 140.1% |
| DCF (EBITDA 5y) | 7,638.40 - 9,383.92 | 8,342.63 | 83.0% |
| DCF (EBITDA 10y) | 8,861.68 - 11,444.03 | 9,937.17 | 117.9% |
| Fair Value | 2,883.17 - 2,883.17 | 2,883.17 | -36.77% |
| P/E | 5,616.53 - 8,476.48 | 6,679.46 | 46.5% |
| EV/EBITDA | (2,319.29) - 10,378.62 | 2,555.72 | -44.0% |
| EPV | 1,860.41 - 2,518.17 | 2,189.29 | -52.0% |
| DDM - Stable | 4,659.92 - 10,337.11 | 7,498.52 | 64.4% |
| DDM - Multi | 4,057.16 - 7,298.13 | 5,243.48 | 15.0% |
| Market Cap (mil) | 89,467.20 |
| Beta | 0.27 |
| Outstanding shares (mil) | 19.62 |
| Enterprise Value (mil) | 81,657.57 |
| Market risk premium | 5.82% |
| Cost of Equity | 7.34% |
| Cost of Debt | 5.50% |
| WACC | 6.55% |